Eevia Health Plc (“Eevia” or the “Company”) will present at the Nutrition Capital Network’s Ingredient Technology Investor Meeting today in Mandalay Bay, Las Vegas. The presentation will showcase one of Eevia’s innovations in nutrition science to Ingredient Technology Investors, with a focus on a pipeline eye-health solution.
Eevia has been selected by a panel of nutraceutical experts and investors organized by the Nutrition Capital Network (NCN) to present at the NCN Ingredient Technology Investor Meeting today, October 29, 2024, at 3:00 pm PDT (UTC -8).
Over 100 category-focused investors will meet at Mandalay Bay, Las Vegas. The NCN event is co-located with the nutraceutical tradeshow SupplySide West, which runs this week.
A team from Eevia will attend the NCN event to meet investors and at Supply Side West to meet customers. The presentation at the NCN event will showcase Eevia’s innovation in eye-health nutrition science to Ingredient Technology Investors.
Presenting at the NCN event provides visibility directly to top-tier category investors. The event also offers mentorship through feedback from industry experts to sharpen our go-to-market strategy, exclusive 1-on-1 access to investors, and networking opportunities.
A copy of the pitch deck that will be presented at the NCN event is attached to this release.
Learn more about the NCN event here.
For more information, please contact:
Stein Ulve, CEO
stein.ulve@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as Bilberry, lingonberry, Chaga mushroom, and pine bark, are wild-harvested sustainably.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.
